New COVID-19 cases in India cross the 800/day mark

Even as discussions about the continuation of the national lockdown continues, India has seen a record number of new COVID-19 patients in the last 24 hours. According to various crowd-sourced data sources, a total of 809 new cases of Coronavirus infections were reported in the last 24 hours (official confirmation expected today afternoon). This is […]

RISING COVID-19 CASES: Is India’s lock-down a total failure?

The first case of COVID-19 in India was reported 67 days ago on January 30 in Kerala. It was only after 55 days that India imposed a countrywide lockdown to prevent the virus from spreading. In those 55 days, the Coronavirus infected around 500 people — at an average rate of 9 new infections per […]

COVID-19: Kerala likely to increase liquor outlets to prevent crowding

Kerala Government may radically expand the number of liquor outlets in the state by tomorrow to prevent crowding at the existing outlets. Kerala State Beverages Corporation, along with Kerala State Co-operatives Consumers’ Federation, has a legal monopoly over the retailing of liquor in Kerala. However, with only around 300 outlets to serve a population of […]

CORONAVIRUS: Superstar Mohanlal calls for magical clapping

Malayalam Superstar Mohanlal expressed frustration at the high number of people who are refusing to heed government’s instructions on combating Coronavirus, and compared community clapping to magic that can destroy bacteria and viruses. “It won’t do to just say that we are not used to [such restrictions],” Mohanlal said in an interview with Malayalam channel […]

AYUSH Ministry hits back over criticism of Coronavirus advisory

The ministry of traditional medicines at Government of India has hit back at critics who have questioned the medical validity of its recent advisory on countering Coronavirus through herbal medicine. The AYUSH ministry had issued a list of dos and don’ts last week, including items such as ensuring proper personal hygiene, wearing face masks in […]

Biocon gets Form 483 observations for API plant

The US Food and Drug Administration has issued a Form 483 with five observations for Biocon’s API Manufacturing facility. Form 483 observations are issued when US FDA inspectors notice shortcomings in a company’s manufacturing processes, data storage and so on during an inspection. The company has to address the issues raised in the Form 483 […]

Alembic gets two observations for Karkhadi plant

Alembic Pharmaceuticals, one of India’s biggest drug makers, received two observations from US FDA officials who inspected its plant at Karkhadi in Gujarat. Observations, given in Form 483, indicate that the inspectors were not fully satisfied with what they found during the visit. In a Form 483, the FDA typically outlines conditions or practices at […]

Natco Pharma seeks nod for generic copy of Taiho’s cancer drug Lonsurf

India-based Natco Pharma has filed an application with the US Food and Drug Administration seeking permission to market a generic copy of Lonsurf, a drug approved just four years ago to treat colorectal/gastric cancers. The application has been filed with a ‘Paragraph IV’ declaration. Such a declaration essentially states that the filer, Natco, believes that […]

Sun Pharma launches dry-eye treatment in the US

Sun Pharmaceutical Industries Ltd said one of its wholly-owned subsidiaries has commercialized CEQUA (cyclosporine ophthalmic solution) 0.09% in the U.S. CEQUA, which offers the highest concentration of cyclosporine for ophthalmic use approved by the U.S. Food and Drug Administration (FDA), is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye), an inflammatory […]

Morepen Labs readies multi-billion APIs for manufacturing from Dec

Pharmaceuticals manufacturer Morepen Laboratories Ltd said it is ready to start manufacturing and selling three multi-billion dollar drugs, two of which are set to go off-patent in December this year. The current global market size for Rivaroxaban, a powerful anticoagulant (blood thinner), is $7.19 billion (Rs. 51,000 cores). It is the 10th largest selling drug […]

Lupin appoints Apotex veteran as new head of quality

Pharmaceuticals maker Lupin has appointed a new head of quality for the company, as it strives to remain compliant with international safety and manufacturing norms throughout its vast manufacturing base across the world. Johnny Mikell, the new global head of quality, comes from a similar role at Canada-based pharmaceutical manufacturer Apotex, and has 35 years […]

Thyrocare board says no to founder Velumani’s offer to buy scanning arm

Directors of diagnostic chain Thyrocare today said no to founder and chairman Arokiaswamy Velumani’s offer to buy out its latest venture aimed at democratising access to cancer diagnostic services. At present, cancer screening and diagnostic services are extremely expensive, and Velumani — the son of a landless farmer — has been working for some time […]

Lupin sells Japanese injectables business to UAE-based Neopharma

Pharma major Lupin said it has agreed to sell its Japanese injectables business to a wholly owned subsidiary of Neopharma group, the UAE’s largest pharmaceutical manufacturer headquartered in Abu Dhabi. Lupin has agreed to sell all the issued and outstanding share capital in its unit Kyowa Criticare Co. Ltd to neo ALA Co. Ltd, a […]